OSAKA - Ono Pharmaceutical Co., which sells a cancer treatment drug based on the discoveries of Japanese Nobel laureate in medicine Tasuku Honjo, has decided to make a new proposal to him in an attempt to settle a dispute over a license fee, a company source said Saturday.
Sorry. This article is no longer available.
Sorry, this article was first published more than three months ago and is temporarily unavailable.
Once the upcoming introduction of a paid membership system is fully operational, paid members will have access to all our stories.
Free Membership Provides
Newsletter from Editorial Team and access to archive articles from past three months.
By continuing, you agree to the Terms of Use,
and Privacy Policy.
